Ufp Technologies (UFPT) Return on Capital Employed (2011 - 2026)
Ufp Technologies (UFPT) reported Return on Capital Employed of 15.75% for Q1 2026, down 10.0% on a YoY basis from 17.5% in Q1 2025, and down 1.24% quarter-over-quarter from 15.95% in Q4 2025.
Ufp Technologies (UFPT) Return on Capital Employed (2011 - 2026) Analysis & Trends
Ufp Technologies has reported Return on Capital Employed for 16 years, with the latest figure at 15.75% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed fell 10.0% year-over-year to 15.75%; the trailing twelve-month figure through Mar 2026 stood at 15.75% (down 10.0% YoY), and the FY2025 full-year result was 16.28%, down 209.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 15.75%, down from 15.95% in the prior quarter.
- The five-year high for Return on Capital Employed was 19.54% in Q2 2023, with the low at 7.19% in Q1 2022.
- Historically, Return on Capital Employed has averaged 15.52% across 5 years, with a median of 16.3% in 2023.
- Annual changes were most pronounced in 2023 — Return on Capital Employed soared 1143 bps — and 2024, when it plunged 257 bps.
- Ufp Technologies' Return on Capital Employed stood at 16.93% in 2022, then dropped by 1 bps to 16.77% in 2023, then decreased by 13 bps to 14.51% in 2024, then rose by 10 bps to 15.95% in 2025, then retreated by 1 bps to 15.75% in 2026.
- The last three Return on Capital Employed figures came in at 15.75% (Q1 2026), 15.95% (Q4 2025), and 16.58% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 11.57% |
| 10 | Ufp Technologies | 1.85 Bn | 1.83 Bn | 44.36 Mn | 15.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.75% |
| Dec 31, 2025 | 15.95% |
| Sep 30, 2025 | 16.58% |
| Jun 30, 2025 | 16.59% |
| Mar 31, 2025 | 15.85% |
| Dec 31, 2024 | 14.51% |
| Sep 30, 2024 | 15.79% |
| Jun 30, 2024 | 16.97% |
| Mar 31, 2024 | 17.19% |
| Dec 31, 2023 | 16.77% |
| Sep 30, 2023 | 16.30% |
| Jun 30, 2023 | 19.54% |
| Mar 31, 2023 | 18.62% |
| Dec 31, 2022 | 16.93% |
| Sep 30, 2022 | 14.71% |
| Jun 30, 2022 | 8.68% |
| Mar 31, 2022 | 7.19% |
| Dec 31, 2021 | 8.89% |
| Sep 30, 2021 | 10.75% |
| Jun 30, 2021 | 10.42% |